Banawan, Jushfer .

HRN: 26-20-03  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/26/2025
CEFUROXIME 750MG (VIAL)
07/26/2025
08/02/2025
IV
320mg
Q8H
PCAP C
Pending Pharmacy Acceptance 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Pneumonia    Compliance to guidelines: